Búsqueda - Portal Conocimiento Público CL

Article 2018-05

Somatotropic axis dysfunction in non-alcoholic fatty liver disease: Beneficial hepatic and systemic effects of hormone supplementation

Autor: Cabrera, D. Cabello-Verrugio, C. Solís, N. Martín, D.S. Cofré, C. Pizarro, M. Arab, J.P. Abrigo, J. Campos, F. Irigoyen, B. Carrasco-Avino, G. Bezares, K. Riquelme, V. Riquelme, A. Arrese, M. Barrera, F.

Background: Somatotropic axis dysfunction associated with non-alcoholic fatty liver disease (NAFLD) has potential multisystemic detrimental effects. Here, we analysed the effects of growth hormone (GH) and insulin-like growth factor-1 (IGF-1) supplementation on liver histology, adipokine profile ...

Enlace original: http://repositorio.unab.cl/xmlui/handle/ria/8891

Repositorio Universidad Andrés Bello

Fatty liver

Growth hormone

IGF-1

Listar archivos Citar Enlace permanente

Cabrera, D. , Cabello-Verrugio, C. , Solís, N. , Martín, D.S. , Cofré, C. , Pizarro, M. , Arab, J.P. , Abrigo, J. , Campos, F. , Irigoyen, B. , Carrasco-Avino, G. , Bezares, K. , Riquelme, V. , Riquelme, A. , Arrese, M. , Barrera, F. , [Somatotropic axis dysfunction in non-alcoholic fatty liver disease: Beneficial hepatic and systemic effects of hormone supplementation] , Somatotropic axis dysfunction in non-alcoholic fatty liver disease: Beneficial hepatic and systemic effects of hormone supplementation

Article 2016-04

Angiotensin-(1-7) attenuates disuse skeletal muscle atrophy in mice via its receptor, Mas

Autor: Morales, M.G. Abrigo, J. Acuna, M.J. Santos, R.A. Bader, M. Brandan, E. Simon, F. Olguin, H. Cabrera, D. Cabello-Verrugio, C.

Immobilization is a form of disuse characterized by a loss of strength and muscle mass. Among the main features are decreased IGF-1/Akt signalling and increased ubiquitin-proteasome pathway signalling, which induce greater myosin heavy chain degradation. Activation of the classical renin-angioten...

Enlace original: http://repositorio.unab.cl/xmlui/handle/ria/3994

Repositorio Universidad Andrés Bello

Angiotensin-(1-7)

Atrophy

Disuse

Listar archivos Citar Enlace permanente

Morales, M.G. , Abrigo, J. , Acuna, M.J. , Santos, R.A. , Bader, M. , Brandan, E. , Simon, F. , Olguin, H. , Cabrera, D. , Cabello-Verrugio, C. , [Angiotensin-(1-7) attenuates disuse skeletal muscle atrophy in mice via its receptor, Mas] , Angiotensin-(1-7) attenuates disuse skeletal muscle atrophy in mice via its receptor, Mas

Descubre y comparte nuestro conocimiento público

Resultados de búsqueda

Somatotropic axis dysfunction in non-alcoholic fatty liver disease: Beneficial hepatic and systemic effects of hormone supplementation

Angiotensin-(1-7) attenuates disuse skeletal muscle atrophy in mice via its receptor, Mas

Descubre y comparte nuestro conocimiento público

Resultados de búsqueda

Somatotropic axis dysfunction in non-alcoholic fatty liver disease: Beneficial hepatic and systemic effects of hormone supplementation

[Cabrera_D_Somatotropic_Axis_Dysfunction.pdf]

Angiotensin-(1-7) attenuates disuse skeletal muscle atrophy in mice via its receptor, Mas

[Morales_M_Angiotensin.pdf]